RAMAT GAN, ISRAEL, June 4, 2024 / EINPresswire.com / -- Medasense, a pioneer in pain monitoring technology, has announced a strategic agreement with Panakeia, LLC, a Service-Disabled Veteran-Owned ...
Medasense Biometrics Ltd. received U.S. FDA marketing authorization for its PMD-200 patient monitor with nociception level index (NOL) technology that monitors patients’ physiological response to pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results